BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
5.55
-0.10 (-1.77%)
At close: Nov 13, 2026, 4:00 PM EST
5.37
-0.18 (-3.32%)
After-hours: Nov 13, 2026, 7:53 PM EST
BioAge Labs Revenue
BioAge Labs had revenue of $298.00K in the quarter ending September 30, 2026, a decrease of -85.49%. This brings the company's total for the last twelve months to $8.60M, up 45.33% year-over-year. In the year 2025, BioAge Labs had annual revenue of $9.00M. That makes BioAge Labs the 38,025th largest company in the world by revenue and 4,986th in the United States.
Revenue (ttm)
$8.60M
Revenue Growth
+45.33%
P/S Ratio
29.66
Revenue / Employee
$138,694
Employees
62
Market Cap
255.07M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.00M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
BIOA News
- 2 days ago - BioAge Labs Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 3 days ago - BioAge Labs to Present at Upcoming Investor Conferences - GlobeNewsWire
- 4 days ago - BioAge Labs Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 5 days ago - BioAge Labs price target lowered to $40 from $73 at Piper Sandler - TheFly
- 8 days ago - BioAge Labs reports Q3 EPS (73c), consensus (63c) - TheFly
- 8 days ago - BioAge Labs Reports Third Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 9 days ago - BioAge Labs Quarterly report: Q3 2026 - Filings
- 9 days ago - BioAge Labs Earnings release: Q3 2026 - Filings